BMS-986506
/ BMS
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 30, 2025
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
(clinicaltrials.gov)
- P1 | N=125 | Not yet recruiting | Sponsor: Bristol-Myers Squibb
First-in-human • New P1 trial • Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor
1 to 1
Of
1
Go to page
1